StonvexLoading…
StonvexStonvexStonvexCore line items from ETS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-02-28 | Annual 2025 2025-11-30 | Q3 2025 2025-08-31 | Q1 2025 2025-02-28 |
|---|---|---|---|---|
Revenue | $805.30K | $2.67M | $1.96M | $692.14K |
Operating Income | $-307.24K | $-2.50M | $-584.57K | $-316.03K |
Net Income | $-110.10K | $-2.19M | $-498.48K | $-205.00K |
EPS (Diluted) | $-0.01 | $-0.16 | $-0.04 | $-0.02 |
Total Assets | $13.35M | $13.71M | $15.19M | Not available |
Total Liabilities | $269.00K | $513.15K | $312.65K | Not available |
Cash & Equivalents | $68.06K | $1.31M | $13.55M | $168.07K |
Free Cash Flow OCF − CapEx | $-1.26M | $-2.91M | $-720.12K | Not available |
Shares Outstanding | 16.72M | 16.72M | 16.72M | 16.92M |